Prices are updated after-hours

Belgium

Celyad SA

CYAD | $0.47 -12.49% 49K

(0.0% 1d) (0.0% 1m) (-26.6% 1y) (0.0% 2d) (-11.1% 3d) (0.0% 7d) (421.67% volume)
Earnings Calendar:
Market Cap: $ 10,619,159
http://www.celyad.com
Sec Filling | Patents | 107 employees

(BE) Celyad Oncology SA engages in the development of cell-based therapies for the treatment of cancer. It operates through the following segments: Cardiology, Immuno-oncology, and Corporate. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-oncology segment consists of all assets developed based on the CAR-T cell platform. The company was founded by Michel Lussier, William Wijns, and Christian Homsy on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.

cancer cardiology car-t t-cell treatment ceiling

add to watch list Paper trade email alert is off

Materialise NV

MTLS | $5.2 3.59% 3.46% 180K

Technology Services

(0.0% 1d) (2.2% 1m) (-37.2% 1y) (0.0% 2d) (6.7% 3d) (5.0% 7d) (160.07% volume)
Earnings Calendar:
Market Cap: $ 307,149,367
http://www.materialise.com
Sec Filling | Patents | 2177 employees

(BE) EMaterialise NV engages in the provision of additive manufacturing software and 3D printing services. It operates through the following business segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment develops and delivers additive manufacturing software solutions and related services. The Materialise Medical segment includes medical software solutions, medical devices and other related products and services. The Materialise Manufacturing segment provides 3D printed services. The company was founded by Wilfried Vancraen on June 28, 1990 and is headquartered in Leuven, Belgium.

3d

add to watch list Paper trade email alert is off

Euronav NV

EURN | $16.35 -0.12% 0.0% 250K

Transportation

(0.0% 1d) (2.0% 1m) (-2.7% 1y) (0.0% 2d) (0.0% 3d) (1.1% 7d) (2.67% volume)
Earnings Calendar:
Market Cap: $ 3,597,404,058
http://www.euronav.com
Sec Filling | Patents | 2910 employees

(BE) Euronav NV engages in the transportation and storage of crude oil. It operates through the Tankers and FpSO (Floating Production, Storage, and Offloading Operation) segments. The Tankers segment provides shipping services for crude oil seaborne transportation. The FpSO segment receives hydrocarbon fluids pumped by nearby offshore platforms and provides field storage. Its activities include crew, ship, and fleet management services. The company was founded in 1989 and is headquartered in Antwerp, Belgium.

crude oil

add to watch list Paper trade email alert is off

Nyxoah SA

NYXH | $10.23 -1.64% -1.66% 26K

n/a

(0.0% 1d) (-30.2% 1m) (0.1% 1y) (0.0% 2d) (8.9% 3d) (16.9% 7d) (-29.74% volume)
Earnings Calendar:
Market Cap: $ 293,212,107
https://www.nyxoah.com/
Sec Filling | Patents | 2021 employees

(BE) Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA).

add to watch list Paper trade email alert is off

KBC Group NV

KBCSY | $37.1025 -5.06% 10K

Finance and Insurance

(0.0% 1d) (-1.0% 1m) (2.4% 1y) (0.0% 2d) (1.1% 3d) (2.7% 7d) (-41.12% volume)
Earnings Calendar:
Market Cap: $ 30,966,182,529
https://www.kbc.com
Sec Filling | Patents | n/a employees

(BE)

add to watch list Paper trade email alert is off

UCB S.A.

UCBJY | $63.676 -4.38% 7.2K

Manufacturing

(0.0% 1d) (6.7% 1m) (34.2% 1y) (0.0% 2d) (0.7% 3d) (2.4% 7d) (-95.07% volume)
Earnings Calendar:
Market Cap: $ 24,770,684,558
https://www.ucb.com
Sec Filling | Patents | n/a employees

(BE)

add to watch list Paper trade email alert is off

Umicore/ADR

UMICY | $5.56 0.18% 320K

Manufacturing

(0.0% 1d) (-1.2% 1m) (-30.4% 1y) (0.0% 2d) (-1.2% 3d) (-0.5% 7d) (-43.27% volume)
Earnings Calendar:
Market Cap: $ 5,479,936,000
https://www.umicore.be/
Sec Filling | Patents | n/a employees

(BE)

add to watch list Paper trade email alert is off

Proximus

BGAOY | $1.5 38.89% 1.1K

Information

(0.0% 1d) (4.2% 1m) (-16.2% 1y) (0.0% 2d) (0.0% 3d) (6.7% 7d) (-26.27% volume)
Earnings Calendar:
Market Cap: $ 2,535,188,513
https://www.proximus.com/
Sec Filling | Patents | n/a employees

(BE)

add to watch list Paper trade email alert is off

Barco NV

BCNAY | $14.1 0

Manufacturing

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-1.96% volume)
Earnings Calendar:
Market Cap: $ 2,620,249,389
https://www.barco.com/
Sec Filling | Patents | n/a employees

(BE)

add to watch list Paper trade email alert is off

bpost SA/NV/ADR

BPOSY | $3.805 83.33% 19K

Transportation and Warehousing

(0.0% 1d) (13.2% 1m) (-37.0% 1y) (0.0% 2d) (1.7% 3d) (0.0% 7d) (3693.52% volume)
Earnings Calendar:
Market Cap: $ 761,003,592
http://www.bpost.be/
Sec Filling | Patents | n/a employees

(BE)

add to watch list Paper trade email alert is off

SOLVAY S A /ADR/

SVYSF | $32.85 278.5% 2.2K

Process Industries

(0.0% 1d) (2.4% 1m) (-70.5% 1y) (0.0% 2d) (2.4% 3d) (3.7% 7d) (112.64% volume)
Earnings Calendar:
Market Cap: $ 3,478,040,266
http://www.solvay.com
Sec Filling | Patents | n/a employees

(BE) Solvay SA engages in the manufacture and distribution of chemical and plastic products. It operates through the following segments: Advanced Formulations, Advanced Materials, Performance Chemicals and Corporate and Business Services. The Advanced Formulations segment offers specialty formulations that impact surface chemistry and alter liquid behavior. The Advanced Materials segment materials for multiple applications primarily in the automotive, aerospace, electronics and health markets. The Performance Chemicals segment operates in mature and resilient markets and has positions in chemical intermediates. The Corporate and Business Services segment includes corporate and other business services, such as the research & innovation center. The company was founded by Ernest Solvay in 1863 and is headquartered in Brussels, Belgium.

automotive electronics

add to watch list Paper trade email alert is off

MDxHealth SA - ADR

MDXH | $2.37 1.72% 1.69% 48K

Professional, Scientific, and T...

(0.0% 1d) (2.8% 1m) (-35.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-47.26% volume)
Earnings Calendar:
Market Cap: $ 64,672,780
https://mdxhealth.com/
Sec Filling | Patents | 123 employees

(BE) photocure, the world leader in photodynamic technology, is a norwegian based specialty pharmaceutical company. we develop and commercialize highly selective and effective solutions in several disease areas such as bladder cancer, colorectal cancer, hpv and precancerous lesions of the cervix, acne and other dermatologic conditions.based on our proprietary photocure technology® platform, we are continually expanding our product portfolio. our aim is to improve patient care and quality of life by making solutions based on photocure technology® accessible to patients and consumers worldwide. photocure was founded by the norwegian radium hospital in 1997. today, the company, headquartered in oslo, norway, has over 60 highly skilled employees and operates in norway, sweden, denmark, finland and the united states.

add to watch list Paper trade email alert is off

UCB S.A.

UCBJF | $126.05 -39.66% 100

Health Technology

(0.0% 1d) (7.4% 1m) (31.0% 1y) (0.0% 2d) (0.0% 3d) (2.1% 7d) (645.0% volume)
Earnings Calendar:
Market Cap: $ 24,517,438,191
http://www.ucb.com
Sec Filling | Patents | n/a employees

(BE) UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.

add to watch list Paper trade email alert is off

Umicore/ADR

UMICF | $21.85 44.36% 1.6K

Non-Energy Minerals

(0.0% 1d) (-1.4% 1m) (-30.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (172900.0% volume)
Earnings Calendar:
Market Cap: $ 5,383,840,000
http://www.umicore.com
Sec Filling | Patents | n/a employees

(BE) Umicore engages in the materials technology business. It operates through the following business segments: Catalysis, Energy & Surface Technologies, Recycling, and Corporate. The Catalysis segment is consist of automotive catalysts for gasoline and diesel light and heavy duty diesel applications, including on-road and non-on-road vehicles. The Energy and Surface Technologies segment is comprised of cobalt and specialty materials, electro-optic materials, electroplating, rechargeable battery materials and thin film products business units. The Recycling segment offers precious metals refining, jewellery and industrial metals, precious metals management, technical materials, and platinum engineer materials. The Corporate segment covers corporate activities, shared operational functions, and research, development, innovation unit of the group. The company was founded on July 7, 1904 and is headquartered in Brussels, Belgium.

vehicles battery batteries energy automotive optical

add to watch list Paper trade email alert is off

Proximus

BGAOF | $8.335 30.9% 360

Communications

(0.0% 1d) (0.0% 1m) (-10.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-23.82% volume)
Earnings Calendar:
Market Cap: $ 2,817,439,500
http://www.proximus.com
Sec Filling | Patents | n/a employees

(BE) Proximus SA engages in the provision of telecommunication services. It operates its business through the following segments: Consumer Business Unit (CBU); Enterprise Business Unit (EBU); Technology Unit (TEC); Wholesale Unit (WU); International Carrier Services (ICS); and Staff and Support (S&S). The CBU segment sells voice products and services, internet and television, both on fixed mobile networks. The EBU segment markets information and communication technology services and products to professional customers under the Proximus and Telindus brand names. The TEC segment centralizes all network and costs and supplies. The Wholesale Unit segment offers services to other telecom and cable operators. The ICS segment is responsible for the international carrier activities. The S&S segment brings together all the horizontal functions, such as human resources, finance, legal, strategy, and corporate communication; internal services, and real estate that support the Group's activities. The company was founded on September 4, 1992 and is headquartered in Brussels, Belgium.

brands c-abl communication

add to watch list Paper trade email alert is off

GALAPAGOS NV

GLPGF | News | $35.5157 71.75% 4.8K

Health Technology

(0.0% 1d) (0.0% 1m) (-6.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (240500.0% volume)
Earnings Calendar:
Market Cap: $ 2,274,107,918
http://www.glpg.com
Sec Filling | Patents | n/a employees

(BE) Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

antibody 3d

add to watch list Paper trade email alert is off

Barco NV

BCNAF | $16.0 44.46% 100

Electronic Technology

(0.0% 1d) (0.0% 1m) (-46.7% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (3233.33% volume)
Earnings Calendar:
Market Cap: $ 1,486,666,320
http://www.barco.com
Sec Filling | Patents | n/a employees

(BE) Barco NV engages in designing and developing visualization solutions. It operates through the following segments: Entertainment, Enterprise and Healthcare. The Entertainment segment is responsible for the delivery of projection, lighting, LED and software solutions for professional markets such as cinema, venues, and hospitality, retail and advertising. The Enterprise segment targets both the corporate and the control rooms market and offers a complete portfolio of visualization solutions with video walls, corporate projectors in combination with collaboration software, networking and connectivity capabilities. The Healthcare segment offers displays for the diagnostic and modality imaging in the field of radiology, mammography, surgery and dentistry, along with digital networked solutions for the operating room and point-of-care devices. The company was founded in 1934 and is headquartered in Kortrijk, Belgium.

diagnostics

add to watch list Paper trade email alert is off

Anheuser-Busch InBev SA/NV

BUDFF | $56.964 -0.44% 52K

Consumer Non-Durables

(0.0% 1d) (-1.7% 1m) (-11.1% 1y) (0.0% 2d) (0.0% 3d) (0.4% 7d) (-99.77% volume)
Earnings Calendar:
Market Cap: $ 103,429,305,748
http://www.ab-inbev.com
Sec Filling | Patents | n/a employees

(BE) Anheuser-Busch InBev SA/NV operates as a holding company, which engages in the manufacture and distribution of alcoholic and non-alcoholic beverages. It operates through the following geographical segments: North America, Latin America West, Latin America North, Latin America South, EMEA, Asia Pacific and Global Export and Holding Companies. The Global Export and Holding Companies segment includes the global headquarters and the export businesses in other countries. Its brands include Budweiser, Corona and Stella Artois; multi-country brands Beck's, Castle, Castle Lite, Hoegaarden and Leffe; and local champions, such as Aguila, Antarctica, Bud Light, Brahma, Cass, Chernigivske, Cristal, Harbin, Jupiler, Klinskoye, Michelob Ultra, Modelo Especial, Quilmes, Victoria, Sedrin, Sibirskaya Korona, and Skol. The company was founded on August 2, 1977 and is headquartered in Leuven, Belgium.

brands msa

add to watch list Paper trade email alert is off

KBC Group NV

KBCSF | $73.25 -8.22% 160

Finance

(0.0% 1d) (1.0% 1m) (3.8% 1y) (0.0% 2d) (0.0% 3d) (1.4% 7d) (1061.9% volume)
Earnings Calendar:
Market Cap: $ 30,567,655,417
http://www.kbc.com
Sec Filling | Patents | n/a employees

(BE) KBC Group NV engages in the provision of integrated bank-insurances. It operates through the following segments: Belgium Business; Czech Republic Business; and International Markets Business Unit. The Belgium Business segment engages in the retail and private banc assurance activities in Belgium. The Czech Republic Business segment comprises all KBC's activities in the Czech Republic. The International Markets Business Unit segment comprises the activities conducted by entities in the other Central and Eastern European core countries. The company was founded on February 9, 1935 and is headquartered in Brussels, Belgium.

add to watch list Paper trade email alert is off

Celyad Oncology SA

CLYYF | $0.4138 -2.36% -1.88% 0

n/a

(0.0% 1d) (0.0% 1m) (-21.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-24.81% volume)
Earnings Calendar:
Market Cap: $ 10,975,932
http://www.celyad.com
Sec Filling | Patents | n/a employees

(BE) Celyad Oncology SA engages in the development of cell-based therapies for the treatment of cancer. It operates through the following segments: Cardiology, Immuno-oncology, and Corporate. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-oncology segment consists of all assets developed based on the CAR-T cell platform. The company was founded by Michel Lussier, William Wijns, and Christian Homsy on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.

ceiling cancer treatment t-cell

add to watch list Paper trade email alert is off